Page last updated: 2024-10-26

dicyclomine and Colorectal Cancer

dicyclomine has been researched along with Colorectal Cancer in 1 studies

Dicyclomine: A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.
dicyclomine : The ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularly that associated with irritable bowel syndrome.

Research Excerpts

ExcerptRelevanceReference
"Incidence rates of colorectal cancer (CRC) are increasing among adults born in and after the 1960s, implicating pregnancy-related exposures introduced at that time as risk factors."3.01In utero exposure to antiemetic and risk of adult-onset colorectal cancer. ( Cirillo, PM; Cohn, BA; Krigbaum, NY; Murphy, CC; Singal, AG, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Murphy, CC1
Cirillo, PM1
Krigbaum, NY1
Singal, AG1
Cohn, BA1

Reviews

1 review available for dicyclomine and Colorectal Cancer

ArticleYear
In utero exposure to antiemetic and risk of adult-onset colorectal cancer.
    JNCI cancer spectrum, 2023, 03-01, Volume: 7, Issue:2

    Topics: Adult; Antiemetics; Colorectal Neoplasms; Dicyclomine; Female; Humans; Mothers; Pregnancy; Prenatal

2023